A Single-dose-oral, Ascending-Dose, Single-Center,Randomized, Double-Blind, Placebo-Parallel-controlled Study for the Evaluation of the Effect of TPN171H Tablets on the QT/QTc Intervals in Adult Healthy Subjects
Latest Information Update: 10 Apr 2023
At a glance
- Drugs Simmerafil (Primary)
- Indications Erectile dysfunction; Pulmonary arterial hypertension
- Focus Therapeutic Use
- Sponsors Vigonvita Life Sciences
Most Recent Events
- 04 Apr 2023 Status changed from recruiting to completed.
- 08 Mar 2023 New trial record